Muscle Pain Tablet Franchise in Ahmedabad

Pain Relief Medicine Supplier in Mumbai

Ortho Medicine Distributor in Delhi

Pain Relief Tablet Manufacturer in Bangalore

Muscle Relaxant Tablet Stockist in Hyderabad
Ortho Tablet Exporter in Chandigarh

Home/Products /eperisone-150mg-aceclofenac-100mg-paracetamol-325mg-tablet

Aceflick EP 150 Tablet

Composition : Eperisone (150mg) + Aceclofenac (100mg) + Paracetamol (325mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Aceflick EP 150 Tablet containing Eperisone, Aceclofenac, and Paracetamol is used for the management of musculoskeletal pain and muscle spasms. It helps in reducing pain, relieving stiffness, and improving mobility.

Eperisone works as a muscle relaxant to relieve muscle stiffness, Aceclofenac provides anti-inflammatory action, and Paracetamol offers effective pain relief. This combination ensures comprehensive management of pain and spasm conditions.

The tablet is widely prescribed in orthopedic and general practice for back pain, joint pain, and muscle-related conditions, leading to strong demand and repeat usage.

With increasing cases of musculoskeletal disorders and high demand for combination pain relief therapies, this product offers excellent business potential for retailers and distributors. Its fast relief action, consistent prescription demand, and wide patient base make it a fast-moving product that can drive steady sales and growth in the pain management segment.

Read More

About the Product

Aceflick EP 150 Tablet containing Eperisone, Aceclofenac, and Paracetamol is used for the management of musculoskeletal pain and muscle spasms. It helps in reducing pain, relieving stiffness, and improving mobility.

Eperisone works as a muscle relaxant to relieve muscle stiffness, Aceclofenac provides anti-inflammatory action, and Paracetamol offers effective pain relief. This combination ensures comprehensive management of pain and spasm conditions.

The tablet is widely prescribed in orthopedic and general practice for back pain, joint pain, and muscle-related conditions, leading to strong demand and repeat usage.

With increasing cases of musculoskeletal disorders and high demand for combination pain relief therapies, this product offers excellent business potential for retailers and distributors. Its fast relief action, consistent prescription demand, and wide patient base make it a fast-moving product that can drive steady sales and growth in the pain management segment.

Some patients may experience nausea, dizziness, drowsiness, gastric irritation, or dry mouth. Rarely, liver enzyme elevation, gastrointestinal bleeding, or allergic reactions may occur and require medical attention.

Aceflick EP 150 Tablet is indicated for the management of acute musculoskeletal pain, muscle spasms, cervical pain, back pain, and inflammatory joint conditions such as spondylitis or osteoarthritis. It helps reduce pain, relax muscles, and improve functional movement.

This medicine should be used under medical supervision. Patients with liver, kidney, or gastrointestinal disorders should use it cautiously. Avoid alcohol consumption and do not exceed the recommended dose due to risk of liver and gastric complications.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation